Long-Term Safety and Efficacy of Secukinumab in Treatment of Spondyloarthropathies

Impact of Secukinumab and Adalimumab on Novel Mortality NMR-Derived Multimarkers in Patients with Psoriasis: Analyses From Two Randomized Placebo-Controlled Trials (Late Breaking)

COSENTYX® (secukinumab) Mechanism of Action in Dermatology | Novartis PRO Portal

How to inject Cosentyx

FDA Approves Novartis' Cosentyx To Treat Plaque Psoriasis In Pediatric Patients